PUBLICATION
GREM1 is associated with metastasis and predicts poor prognosis in ER-negative breast cancer patients
- Authors
- Neckmann, U., Wolowczyk, C., Hall, M., Almaas, E., Ren, J., Zhao, S., Johannessen, B., Skotheim, R.I., Bjørkøy, G., Ten Dijke, P., Holien, T.
- ID
- ZDB-PUB-200715-28
- Date
- 2019
- Source
- Cell communication and signaling : CCS 17: 140 (Journal)
- Registered Authors
- Keywords
- 4T1 model, 66cl4, 67NR, BMP4, GREM1, Gremlin 1, Metastasis
- MeSH Terms
-
- Animals
- Breast Neoplasms/diagnosis
- Breast Neoplasms/genetics
- Breast Neoplasms/metabolism*
- Breast Neoplasms/pathology*
- Cell Line, Tumor
- Cell Transformation, Neoplastic
- Female
- Gene Expression Regulation, Neoplastic
- Humans
- Intercellular Signaling Peptides and Proteins/genetics
- Intercellular Signaling Peptides and Proteins/metabolism*
- Mice
- Neoplasm Invasiveness
- Neoplasm Metastasis
- Prognosis
- RNA, Messenger/genetics
- Receptors, Estrogen/metabolism
- Survival Analysis
- Trastuzumab
- Zebrafish
- PubMed
- 31694641 Full text @ Cell Commun. Signal.
Citation
Neckmann, U., Wolowczyk, C., Hall, M., Almaas, E., Ren, J., Zhao, S., Johannessen, B., Skotheim, R.I., Bjørkøy, G., Ten Dijke, P., Holien, T. (2019) GREM1 is associated with metastasis and predicts poor prognosis in ER-negative breast cancer patients. Cell communication and signaling : CCS. 17:140.
Abstract
Background In breast cancer, activation of bone morphogenetic protein (BMP) signaling and elevated levels of BMP-antagonists have been linked to tumor progression and metastasis. However, the simultaneous upregulation of BMPs and their antagonist, and the fact that both promote tumor aggressiveness seems contradictory and is not fully understood.
Methods We analyzed the transcriptomes of the metastatic 66cl4 and the non-metastatic 67NR cell lines of the 4T1 mouse mammary tumor model to search for factors that promote metastasis. CRISPR/Cas9 gene editing was used for mechanistic studies in the same cell lines. Furthermore, we analyzed gene expression patterns in human breast cancer biopsies obtained from public datasets to evaluate co-expression and possible relations to clinical outcome.
Results We found that mRNA levels of the BMP-antagonist Grem1, encoding gremlin1, and the ligand Bmp4 were both significantly upregulated in cells and primary tumors of 66cl4 compared to 67NR. Depletion of gremlin1 in 66cl4 could impair metastasis to the lungs in this model. Furthermore, we found that expression of Grem1 correlated with upregulation of several stem cell markers in 66cl4 cells compared to 67NR cells. Both in the mouse model and in patients, expression of GREM1 associated with extracellular matrix organization, and formation, biosynthesis and modification of collagen. Importantly, high expression of GREM1 predicted poor prognosis in estrogen receptor negative breast cancer patients. Analyses of large patient cohorts revealed that amplification of genes encoding BMP-antagonists and elevation of the corresponding transcripts is evident in biopsies from more than half of the patients and much more frequent for the secreted BMP-antagonists than the intracellular inhibitors of SMAD signaling.
Conclusion In conclusion, our results show that GREM1 is associated with metastasis and predicts poor prognosis in ER-negative breast cancer patients. Gremlin1 could represent a novel target for therapy.
Genes / Markers
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Orthology
Engineered Foreign Genes
Mapping